[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Moderator","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Paz Joan Vellanki<\/i><\/u><\/presenter>. FDA Center for Drug Evaluation and Research, Silver Spring, MD","CSlideId":"","ControlKey":"be834b81-d1cf-4dfd-86d6-b7019e2762c7","ControlNumber":"10597","DisclosureBlock":"&nbsp;<b>P.J. Vellanki:<\/b> None.","End":"4\/18\/2023 4:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"9642","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Paz Vellanki, BS;MD;PhD","PresenterKey":"3bfdefb7-db27-4eb1-a4af-97c9055e09f2","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Co-Moderator","SearchResultFooter":"","SearchResultHeader":"Apr 18 2023  2:30PM","SessionId":"692","SessionOnDemand":"False","SessionTitle":"Liquid Biopsies for Curative-Intent Solid Tumor Drug Development","ShowChatLink":"false","Start":"4\/18\/2023 2:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Co-Moderator","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Moderator","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Reena Philip<\/i><\/u><\/presenter>. Food & Drug Administration, Silver Spring, MD","CSlideId":"","ControlKey":"99a00da8-e220-461b-890b-efabf6d7ceb7","ControlNumber":"10596","DisclosureBlock":"&nbsp;<b>R. Philip:<\/b> None.","End":"4\/18\/2023 4:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"9641","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"2","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Reena Philip, PhD","PresenterKey":"61477de8-ad7c-4602-a9b0-5a74f12fc9e0","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Co-Moderator","SearchResultFooter":"","SearchResultHeader":"Apr 18 2023  2:30PM","SessionId":"692","SessionOnDemand":"False","SessionTitle":"Liquid Biopsies for Curative-Intent Solid Tumor Drug Development","ShowChatLink":"false","Start":"4\/18\/2023 2:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Co-Moderator","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Reena Philip<\/i><\/u><\/presenter>. Food & Drug Administration, Silver Spring, MD","CSlideId":"","ControlKey":"85f12034-aea3-4d70-8d28-9b1273f0c547","ControlNumber":"11361","DisclosureBlock":"&nbsp;<b>R. Philip, <\/b> None.","End":"4\/18\/2023 2:32:00 PM","HasWebcast":null,"Highlights":[],"Id":"11102","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"3","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Reena Philip, PhD","PresenterKey":"61477de8-ad7c-4602-a9b0-5a74f12fc9e0","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Opening Remarks","SearchResultFooter":"","SearchResultHeader":"Apr 18 2023  2:30PM","SessionId":"692","SessionOnDemand":"False","SessionTitle":"Liquid Biopsies for Curative-Intent Solid Tumor Drug Development","ShowChatLink":"false","Start":"4\/18\/2023 2:30:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Opening Remarks","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Valsamo K. Anagnostou<\/i><\/u><\/presenter>. Johns Hopkins University, Baltimore, MD","CSlideId":"","ControlKey":"d91ac812-0ee3-42f6-987c-d8d4f590eb79","ControlNumber":"10806","DisclosureBlock":"<b>&nbsp;V. K. Anagnostou, <\/b> <br><b>AstraZeneca<\/b> G, G, G, G, G. <br><b>Bristol-Myers Squibb<\/b> G, G, G, G, G. <br><b>Delfi Diagnostics<\/b> G, G, G, G, G.","End":"4\/18\/2023 2:43:00 PM","HasWebcast":null,"Highlights":[],"Id":"10570","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"4","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Valsamo Anagnostou, MD;PhD","PresenterKey":"aa5c6741-f2c7-4b3c-a7a5-f0a9cbf3b22a","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Speaker","SearchResultFooter":"","SearchResultHeader":"Apr 18 2023  2:30PM","SessionId":"692","SessionOnDemand":"False","SessionTitle":"Liquid Biopsies for Curative-Intent Solid Tumor Drug Development","ShowChatLink":"false","Start":"4\/18\/2023 2:32:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Speaker","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Paz Joan Vellanki<\/i><\/u><\/presenter>. FDA Center for Drug Evaluation and Research, Silver Spring, MD","CSlideId":"","ControlKey":"bc9b6992-2bc6-4ab4-97e0-a55d77de3461","ControlNumber":"11363","DisclosureBlock":"&nbsp;<b>P. J. Vellanki, <\/b> None.","End":"4\/18\/2023 2:50:00 PM","HasWebcast":null,"Highlights":[],"Id":"11104","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"5","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Paz Vellanki, BS;MD;PhD","PresenterKey":"3bfdefb7-db27-4eb1-a4af-97c9055e09f2","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Speaker","SearchResultFooter":"","SearchResultHeader":"Apr 18 2023  2:30PM","SessionId":"692","SessionOnDemand":"False","SessionTitle":"Liquid Biopsies for Curative-Intent Solid Tumor Drug Development","ShowChatLink":"false","Start":"4\/18\/2023 2:43:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Speaker","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Anand Pathak<\/i><\/u><\/presenter>. U.S. Food and Drug Administration, Silver Spring, MD","CSlideId":"","ControlKey":"93c455df-ff6e-4948-aa09-4a78f636772b","ControlNumber":"10807","DisclosureBlock":"&nbsp;<b>A. Pathak, <\/b> None.","End":"4\/18\/2023 4:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10571","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"6","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Anand Pathak, M.D.,Ph.D.","PresenterKey":"b05e38c4-cc0b-4339-aa91-ce3fb5ec69fa","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Panelist","SearchResultFooter":"","SearchResultHeader":"Apr 18 2023  2:30PM","SessionId":"692","SessionOnDemand":"False","SessionTitle":"Liquid Biopsies for Curative-Intent Solid Tumor Drug Development","ShowChatLink":"false","Start":"4\/18\/2023 2:50:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Panelist","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Christopher Abbosh<\/i><\/u><\/presenter>. AstraZeneca Oncology, London, United Kingdom","CSlideId":"","ControlKey":"c18c4a97-a49e-4db6-a225-61b8c1b855b9","ControlNumber":"10834","DisclosureBlock":"","End":"4\/18\/2023 4:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10603","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"7","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Christopher Abbosh, MD,PhD","PresenterKey":"46144995-aa20-4f95-938d-3631b8882f23","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Panelist","SearchResultFooter":"","SearchResultHeader":"Apr 18 2023  2:30PM","SessionId":"692","SessionOnDemand":"False","SessionTitle":"Liquid Biopsies for Curative-Intent Solid Tumor Drug Development","ShowChatLink":"false","Start":"4\/18\/2023 2:50:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Panelist","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Panelist","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Valsamo K. Anagnostou<\/i><\/u><\/presenter>. Johns Hopkins University, Baltimore, MD","CSlideId":"","ControlKey":"02f95acb-d476-4bc8-b6f0-45de151cf773","ControlNumber":"11364","DisclosureBlock":"&nbsp;<b>&nbsp;V.K. Anagnostou:<\/b>  ; AstraZeneca. ; AstraZeneca. ; AstraZeneca. ; AstraZeneca. ; AstraZeneca. ; Bristol-Myers Squibb. ; Bristol-Myers Squibb. ; Bristol-Myers Squibb. ; Bristol-Myers Squibb. ; Bristol-Myers Squibb. ; Delfi Diagnostics. ; Delfi Diagnostics. ; Delfi Diagnostics. ; Delfi Diagnostics. ; Delfi Diagnostics.","End":"4\/18\/2023 4:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"11105","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"8","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Valsamo Anagnostou, MD;PhD","PresenterKey":"aa5c6741-f2c7-4b3c-a7a5-f0a9cbf3b22a","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Panelist","SearchResultFooter":"","SearchResultHeader":"Apr 18 2023  2:30PM","SessionId":"692","SessionOnDemand":"False","SessionTitle":"Liquid Biopsies for Curative-Intent Solid Tumor Drug Development","ShowChatLink":"false","Start":"4\/18\/2023 2:50:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Panelist","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Jonathan Baden<\/i><\/u><\/presenter>. Bristol Myers Squibb, Princeton, NJ","CSlideId":"","ControlKey":"f1887868-62c4-45cc-b619-8d14a31f9bc3","ControlNumber":"10839","DisclosureBlock":"","End":"4\/18\/2023 4:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10611","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"9","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Jonathan Baden, MS","PresenterKey":"8e68efc8-4c04-4de1-b777-8cc0a3266354","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Panelist","SearchResultFooter":"","SearchResultHeader":"Apr 18 2023  2:30PM","SessionId":"692","SessionOnDemand":"False","SessionTitle":"Liquid Biopsies for Curative-Intent Solid Tumor Drug Development","ShowChatLink":"false","Start":"4\/18\/2023 2:50:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Panelist","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>David R. Gandara<\/i><\/u><\/presenter>. UC Davis Comp. Cancer Center, Sacramento, CA","CSlideId":"","ControlKey":"3e5cdab3-44fd-4661-950d-2ac076b287fa","ControlNumber":"10774","DisclosureBlock":"","End":"4\/18\/2023 4:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10508","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"10","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"David Gandara, MD","PresenterKey":"fe39b119-4ea8-4d7e-9d50-ad3ba646ed16","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Panelist","SearchResultFooter":"","SearchResultHeader":"Apr 18 2023  2:30PM","SessionId":"692","SessionOnDemand":"False","SessionTitle":"Liquid Biopsies for Curative-Intent Solid Tumor Drug Development","ShowChatLink":"false","Start":"4\/18\/2023 2:50:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Panelist","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Panelist","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Patricia Spears<\/i><\/u><\/presenter>. University of North Carolina at Chapel Hill, Raleigh, NC","CSlideId":"","ControlKey":"6a2e1756-8e5b-45d2-a84c-7d0a8b8f29d9","ControlNumber":"10933","DisclosureBlock":"&nbsp;<b>&nbsp;P. Spears:<\/b>  ; Pfizer Inc.. ; Pfizer Inc..","End":"4\/18\/2023 4:00:00 PM","HasWebcast":null,"Highlights":[],"Id":"10708","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"11","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Patricia Spears, BS","PresenterKey":"a0fadf34-a718-4587-b570-5263b2781f9d","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Panelist","SearchResultFooter":"","SearchResultHeader":"Apr 18 2023  2:30PM","SessionId":"692","SessionOnDemand":"False","SessionTitle":"Liquid Biopsies for Curative-Intent Solid Tumor Drug Development","ShowChatLink":"false","Start":"4\/18\/2023 2:50:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Panelist","Topics":null,"cSlideId":""}]